| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| 1 | AN ACT concerning health.
| |||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
| 3 | represented in the General Assembly:
| |||||||||||||||||||
| 4 | Section 5. The Illinois Sexually Transmissible Disease | |||||||||||||||||||
| 5 | Control Act is amended by changing Section 6 as follows:
| |||||||||||||||||||
| 6 | (410 ILCS 325/6) (from Ch. 111 1/2, par. 7406)
| |||||||||||||||||||
| 7 | Sec. 6. Physical examination and treatment.
| |||||||||||||||||||
| 8 | (a) Subject to the provisions of subsection (c) of this | |||||||||||||||||||
| 9 | Section, the
Department and its authorized representatives may | |||||||||||||||||||
| 10 | examine or cause to be
examined persons reasonably believed to | |||||||||||||||||||
| 11 | be infected with or to have been
exposed to a sexually | |||||||||||||||||||
| 12 | transmissible disease.
| |||||||||||||||||||
| 13 | (b) Subject to the provisions of subsection (c) of this | |||||||||||||||||||
| 14 | Section, persons
with a sexually transmissible disease shall | |||||||||||||||||||
| 15 | report for complete treatment to a
physician licensed under | |||||||||||||||||||
| 16 | the provisions of the Medical Practice Act of
1987, or shall | |||||||||||||||||||
| 17 | submit to treatment at a facility provided by a local health
| |||||||||||||||||||
| 18 | authority or other public facility, as the Department shall | |||||||||||||||||||
| 19 | require by rule or
regulation until the disease is | |||||||||||||||||||
| 20 | noncommunicable or the Department determines
that the person | |||||||||||||||||||
| 21 | does not present a real and present danger to the public
| |||||||||||||||||||
| 22 | health. This subsection (b) shall not be construed to require | |||||||||||||||||||
| 23 | the Department
or local health authorities to pay for or | |||||||||||||||||||
| |||||||
| |||||||
| 1 | provide such treatment.
| ||||||
| 2 | (c) No person shall be apprehended, examined or treated | ||||||
| 3 | for a sexually
transmissible disease against his will, under | ||||||
| 4 | the provisions of this Act,
except upon the presentation of a | ||||||
| 5 | warrant duly authorized by a court of
competent jurisdiction. | ||||||
| 6 | In requesting the issuance of such a warrant the
Department | ||||||
| 7 | shall show by a preponderance of evidence that the person is
| ||||||
| 8 | infectious and that a real and present danger to the public | ||||||
| 9 | health and
welfare exists unless such warrant is issued and | ||||||
| 10 | shall show that all other
reasonable means of obtaining | ||||||
| 11 | compliance have been exhausted and that no
other less | ||||||
| 12 | restrictive alternative is available. The court shall require
| ||||||
| 13 | any proceedings authorized by this subsection (c) to be | ||||||
| 14 | conducted in
camera. A record shall be made of such | ||||||
| 15 | proceedings but shall be sealed,
impounded and preserved in | ||||||
| 16 | the records of the court, to be made available
to the reviewing | ||||||
| 17 | court in the event of an appeal.
| ||||||
| 18 | (d) Any person who knowingly or maliciously disseminates | ||||||
| 19 | any false
information or report concerning the existence of | ||||||
| 20 | any sexually
transmissible disease under this Section is | ||||||
| 21 | guilty of a Class A misdemeanor.
| ||||||
| 22 | (e) Taking into account the recommendations of the U.S. | ||||||
| 23 | Centers for Disease Control and Prevention and other | ||||||
| 24 | nationally recognized medical authorities, the Department | ||||||
| 25 | shall provide information and technical assistance as | ||||||
| 26 | appropriate to health care professionals who provide expedited | ||||||
| |||||||
| |||||||
| 1 | partner therapy services for persons with sexually | ||||||
| 2 | transmissible diseases. | ||||||
| 3 | (1) Notwithstanding any other provision of law, a | ||||||
| 4 | health care professional who makes a clinical diagnosis of | ||||||
| 5 | chlamydia, or gonorrhea, or trichomoniasis may prescribe, | ||||||
| 6 | dispense, furnish, or otherwise provide prescription | ||||||
| 7 | antibiotic drugs to the infected person's sexual partner | ||||||
| 8 | or partners for the treatment of the sexually | ||||||
| 9 | transmissible disease without physical examination of the | ||||||
| 10 | partner or partners, if in the judgment of the health care | ||||||
| 11 | professional the partner is unlikely or unable to present | ||||||
| 12 | for comprehensive healthcare, including evaluation, | ||||||
| 13 | testing, and treatment for sexually transmissible | ||||||
| 14 | diseases. Expedited partner therapy shall be limited to | ||||||
| 15 | partners who may have been exposed to a sexually | ||||||
| 16 | transmissible disease within the previous 60 days, if the | ||||||
| 17 | patient is able to contact the partner. | ||||||
| 18 | (2) Health care professionals who provide expedited | ||||||
| 19 | partner therapy shall comply with Sections 4 and 5 of the | ||||||
| 20 | Illinois Sexually Transmissible Disease Control Act. | ||||||
| 21 | (3) Health care professionals who provide expedited | ||||||
| 22 | partner therapy shall provide counseling for the patient | ||||||
| 23 | and written materials provided by the Department to be | ||||||
| 24 | given by the patient to the partner or partners that | ||||||
| 25 | include at a minimum the following: | ||||||
| 26 | (A) a warning that a woman who is pregnant or might | ||||||
| |||||||
| |||||||
| 1 | be pregnant must not take certain antibiotics and must | ||||||
| 2 | immediately contact a health care professional for an | ||||||
| 3 | examination, and a recommendation for such an | ||||||
| 4 | examination; | ||||||
| 5 | (B) information about the antibiotic and dosage | ||||||
| 6 | provided or prescribed; clear and explicit allergy and | ||||||
| 7 | side effect warnings, including a warning that a | ||||||
| 8 | partner who has a history of allergy to the antibiotic | ||||||
| 9 | or the pharmaceutical class of antibiotic must not | ||||||
| 10 | take the antibiotic and must be immediately examined | ||||||
| 11 | by a health care professional, and a recommendation | ||||||
| 12 | for such an examination; | ||||||
| 13 | (C) information about the treatment and prevention | ||||||
| 14 | of sexually transmissible diseases; | ||||||
| 15 | (D) the requirement of abstinence until a period | ||||||
| 16 | of time after treatment to prevent infecting others; | ||||||
| 17 | (E) notification of the importance of the partner | ||||||
| 18 | or partners of the patient to receive examination and | ||||||
| 19 | testing for HIV and other sexually transmissible | ||||||
| 20 | diseases, and available resources; | ||||||
| 21 | (F) notification of the risk to self, others, and | ||||||
| 22 | the public health if the sexually transmissible | ||||||
| 23 | disease is not completely and successfully treated; | ||||||
| 24 | (G) the responsibility of the partner or partners | ||||||
| 25 | to inform his or her sex partner or partners of the | ||||||
| 26 | risk of sexually transmissible disease and the | ||||||
| |||||||
| |||||||
| 1 | importance of prompt examination and treatment; and | ||||||
| 2 | (H) other information as deemed necessary by the | ||||||
| 3 | Department. | ||||||
| 4 | (4) The Department shall develop and disseminate in | ||||||
| 5 | electronic and other formats the following written | ||||||
| 6 | materials: | ||||||
| 7 | (A) informational materials for partners, as | ||||||
| 8 | required in item (3) of this subsection (e); | ||||||
| 9 | (B) informational materials for persons who are | ||||||
| 10 | repeatedly diagnosed with sexually transmissible | ||||||
| 11 | diseases; and | ||||||
| 12 | (C) guidance for health care professionals on the | ||||||
| 13 | safe and effective provision of expedited partner | ||||||
| 14 | therapy. | ||||||
| 15 | The Department may offer educational programs about | ||||||
| 16 | expedited partner therapy for health care professionals | ||||||
| 17 | and pharmacists licensed under the Pharmacy Practice Act. | ||||||
| 18 | (5) A health care professional prescribing, | ||||||
| 19 | dispensing, furnishing, or otherwise providing in good | ||||||
| 20 | faith without fee or compensation prescription antibiotics | ||||||
| 21 | to partners under this subsection (e) and providing | ||||||
| 22 | counseling and written materials as required by item (3) | ||||||
| 23 | of this subsection (e) shall not be subject to civil or | ||||||
| 24 | professional liability, except for willful and wanton | ||||||
| 25 | misconduct. A health care professional shall not be | ||||||
| 26 | subject to civil or professional liability for choosing | ||||||
| |||||||
| |||||||
| 1 | not to provide expedited partner therapy. | ||||||
| 2 | (6) A pharmacist or pharmacy shall not be subject to | ||||||
| 3 | civil or professional liability for choosing not to fill a | ||||||
| 4 | prescription that would cause the pharmacist or pharmacy | ||||||
| 5 | to violate any provision of the Pharmacy Practice Act, | ||||||
| 6 | including the definition of "prescription" set forth in | ||||||
| 7 | subsection (e) of Section 3 of the Pharmacy Practice Act | ||||||
| 8 | or the definition of "drug regimen review" set forth in | ||||||
| 9 | subsection (y) of Section 3 of the Pharmacy Practice Act. | ||||||
| 10 | (Source: P.A. 96-613, eff. 1-1-10.)
| ||||||